Skip to main content
SpringerLink
Log in

Hormontherapie nach Brachytherapie der Prostata hinterfragen!

  • Literatur kompakt_Urogenitale Tumoren
  • Published:
Im Focus Onkologie Aims and scope

Welche Faktoren beeinflussen das Langzeitüberleben von Prostatakarzinompatienten, die mit einer Brachytherapie behandelt wurden? Dieser Frage gingen amerikanische Kollegen nach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Stone NN, Stock RG. 15-Year Cause Specific and All-Cause Survival Following Brachytherapy for Prostate Cancer: Negative Impact of Long-Term Hormonal Therapy. J Urol. 2014; 192(3):754-9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Judith Neumaier

  2. Alstertal, Deutschland

    Jörg Zimmermann Kampen (Praxis für Brachytherapie, Praxiszentrum Alstertal)

Authors
  1. Judith Neumaier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jörg Zimmermann Kampen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jörg Zimmermann Kampen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Neumaier, J., Kampen, J.Z. Hormontherapie nach Brachytherapie der Prostata hinterfragen!. Im Focus Onkologie 17, 35 (2014). https://doi.org/10.1007/s15015-014-1499-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-014-1499-x

Search

Navigation